勃起功能障碍
医学
下尿路症状
糖尿病
冠状动脉疾病
疾病
cGMP特异性磷酸二酯酶5型
2型糖尿病
内科学
重症监护医学
内分泌学
癌症
前列腺
作者
Rany Shamloul,Hussein Ghanem
出处
期刊:The Lancet
[Elsevier]
日期:2012-10-05
卷期号:381 (9861): 153-165
被引量:870
标识
DOI:10.1016/s0140-6736(12)60520-0
摘要
Erectile dysfunction is a common clinical entity that affects mainly men older than 40 years. In addition to the classical causes of erectile dysfunction, such as diabetes mellitus and hypertension, several common lifestyle factors, such as obesity, limited or an absence of physical exercise, and lower urinary tract symptoms, have been linked to the development of erectile dysfunction. Substantial steps have been taken in the study of the association between erectile dysfunction and cardiovascular disease. Erectile dysfunction is a strong predictor for coronary artery disease, and cardiovascular assessment of a non-cardiac patient presenting with erectile dysfunction is now recommended. Substantial advances have occurred in the understanding of the pathophysiology of erectile dysfunction that ultimately led to the development of successful oral therapies, namely the phosphodiesterase type 5 inhibitors. However, oral phosphodiesterase type 5 inhibitors have limitations, and present research is thus investigating cutting-edge therapeutic strategies including gene and cell-based technologies with the aim of discovering a cure for erectile dysfunction.
科研通智能强力驱动
Strongly Powered by AbleSci AI